Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by TheMadMonkon Feb 27, 2023 11:15pm
297 Views
Post# 35308679

Perception

Perception It's interesting how some people look at today's price move as a bad thing but I look at it slightly differently.  There are two things that I took away from today's volatility.  The first thing that I am sure other long term investors saw was the chance to pick up some extra shares at a price that I personally wasn't expecting until the dog days of summer.  Sometimes Christmas in July, happens in February?  Don't look a gift horse in the mouth in my opinion.  However, the other thing that I found interesting was, last week when someone wanted to purchase 40,000 shares it drove up the price seven cents.  On the contrary, today when someone (for whatever reason) wanted to exit their position, dumping almost 600,000 shares, there was plenty of buyers willing to scoop them up at a discount and as a result the shares only fell seven cents.  It's all how you look at things, but it seems like a positive thing to me.
<< Previous
Bullboard Posts
Next >>